Distinct serum metabolomics profiles associated with malignant progression in the Kras(G12D) mouse model of pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths worldwide with less than a 6% 5-year survival rate. PDAC is associated with poor prognosis based on the late stage diagnosis of the disease. Current diagnostic tests lack the sensitivity and specificity...

Descripción completa

Detalles Bibliográficos
Autores principales: LaConti, Joseph J, Laiakis, Evagelia C, Mays, Anne Deslattes, Peran, Ivana, Kim, Sung Eun, Shay, Jerry W, Riegel, Anna T, Fornace, Albert J, Wellstein, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315147/
https://www.ncbi.nlm.nih.gov/pubmed/25923219
http://dx.doi.org/10.1186/1471-2164-16-S1-S1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315147/
https://www.ncbi.nlm.nih.gov/pubmed/25923219
http://dx.doi.org/10.1186/1471-2164-16-S1-S1

Ejemplares similares